Literature DB >> 18706525

Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies.

Pier Luigi Meroni, Yehuda Shoenfeld.   

Abstract

Anti-phospholipid antibodies (aPL) are one of the most recent examples of autoantibodies that can appear even long time before any clinical manifestation can be associated with them. There is a general agreement that they may represent a strong risk factor for recurrent thrombosis and/or fetal losses. Anti-phospholipid antibodies represent a necessary but not sufficient factor (first hit) for thrombosis, and require additional triggering factors (second hit) to disclose the thrombogenic activity. Several factors may affect the predictive value of aPL, including titre, immunoglobulin isotype, fine antigenic specificity and affinity binding activity. Their careful evaluation is suggested in order to characterize the true predictive value of aPL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706525     DOI: 10.1016/j.autrev.2008.08.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  11 in total

Review 1.  Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.

Authors:  M Ángeles Martínez-Zamora; Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.

Authors:  Melissa Padovan; Gabriella Castellino; Alessandra Bortoluzzi; Luisa Caniatti; Francesco Trotta; Marcello Govoni
Journal:  Rheumatol Int       Date:  2010-07-31       Impact factor: 2.631

Review 3.  Primary biliary cirrhosis and the nuclear pore complex.

Authors:  Carolina Duarte-Rey; Dimitrios Bogdanos; Chen-Yen Yang; Krista Roberts; Patrick S C Leung; Juan-Manuel Anaya; Howard J Worman; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2012-04-01       Impact factor: 9.754

Review 4.  Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.

Authors:  Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 5.  Autoimmunity and recurrent pregnancy losses.

Authors:  Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 6.  Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent.

Authors:  Marvin J Fritzler
Journal:  Auto Immun Highlights       Date:  2012-03-21

7.  Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.

Authors:  Špela Irman; Miha Škarabot; Igor Muševič; Blaž Rozman; Borut Božič
Journal:  EJIFCC       Date:  2011-01-03

8.  The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).

Authors:  Manuel Serrano; Jose Angel Martinez-Flores; Gary L Norman; Laura Naranjo; Jose Maria Morales; Antonio Serrano
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

9.  Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation.

Authors:  Manuel Serrano; Laura Morán; Jose Angel Martinez-Flores; Esther Mancebo; Daniel Pleguezuelo; Oscar Cabrera-Marante; Juan Delgado; Antonio Serrano
Journal:  Front Immunol       Date:  2019-12-23       Impact factor: 7.561

Review 10.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.